Atxa Therapeutics' Grant

Atxa Therapeutics raised a round of funding on May 15, 2018. Investors include Horizon 2020.

Atxa Therapeutics is focusing on clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension, serving a previously unmet medical need by offering improved treatment opt…

Articles about Atxa Therapeutics' Grant: